Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis

Abstract

Purpose: Subconjunctival corticosteroid injection (SCI) for nonnecrotizing anterior scleritis remains controversial, partly because long-term follow-up is not available. This study documents the efficacy and adverse effects of SCI. Design: Retrospective, noncomparative, interventional case series. Participants: Thirty-eight eyes of 35 patients with nonnecrotizing, noninfectious anterior scleritis resistant to prior systemic or local therapy. Intervention: Subconjunctival triamcinolone acetonide injection. Main Outcome Measure: Persistence or resolution of signs and symptoms of anterior scleritis and development of complications. Results: Thirty-six of 38 eyes had complete resolution of signs..